Health Plans’ Response To Claritin OTC Needs Monitoring For Collusion – WLF
Executive Summary
The Washington Legal Foundation will be monitoring formulary decisions by managed care organizations for evidence of collusion following approval of OTC Claritin
You may also be interested in...
FTC’s Next Chairman Expected To Be Health Care Antitrust Expert Majoras
President Bush intends to nominate health care antitrust attorney Deborah Majoras as Federal Trade Commission chairman
FTC’s Next Chairman Expected To Be Health Care Antitrust Expert Majoras
President Bush intends to nominate health care antitrust attorney Deborah Majoras as Federal Trade Commission chairman
Disclosure Of Drug Costs By Manufacturers To Be Explored In FTC Hearings
Drug companies' disclosure of Rx costs will be considered by the Federal Trade Commission in a series of hearings set to begin in February